Skip to content

Lung perfusion imaging is used in ARDS patient studies

Lung perfusion imaging is used in ARDS patient studies

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DDD-17013998
Enrollment
Unknown
Registered
2017-12-17
Start date
2018-01-01
Completion date
Unknown
Last updated
2018-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ARDS

Interventions

Gold Standard:Clinical symptoms, blood gas analysis, chest X-ray examination
imaging

Sponsors

Tianjin Third Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients with distress, rapid breathing, sudden onset and other conditions, clinical symptoms consistent with ARDS and ARDS-induced risk factors; 2. PaO2 / FiO2 = 300 mmHg, patients showed symptoms of hypoxemia; 3. excluded according to clinical examination Heart-derived pulmonary edema; 4. X-ray chest examination of patients, the patient's lungs can be observed infiltration shadow.

Exclusion criteria

Exclusion criteria: Exclusion criteria: age <18 years, MAP <55mmHg, heart rate <55 beats / min or without pacemaker but there is ? degree atrioventricular block, drug use and long-term analgesia, sedation drug use history and pregnant women.

Design outcomes

Primary

MeasureTime frame
mortality rate;SPE, SEN, ACC, ROC;

Countries

China

Contacts

Public ContactXu Lei

Tianjin Third Central Hospital

nokia007008@163.com+86 13032288771

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026